Metabolic & Weight Management
Mazdutide
GLP-1/glucagon dual receptor agonist studied primarily in Chinese clinical trials for weight and metabolic research.
Weight-management researchMetabolic marker studies
How it works in the body
Liver
Stomach
Pancreas
Adipose Tissue
RESEARCH USE ONLYINVESTIGATIONAL COMPOUNDAvailable following assessmentREGENEXA ASSESSMENT
Vial concentration
Mazdutide
5 mgThis is a clinician-reviewed research peptide. Pricing is provided as part of an approved, personalized plan after your assessment is reviewed.
Not sure where to start?
Discover what may fit your goals — a short, personalized Regenexa Assessment.
Take Your Assessment →- 🔒 Secure & encrypted checkout
- 📦 Fast, discreet worldwide shipping
- 🧪 Pharmaceutical-grade quality
- 🔬 Research use only
Not sure where to start? Discover what may fit your goals — a short, personalized Regenexa Assessment.Take Your Assessment →
Same dual-agonist mechanism class as survodutide; balances GLP-1 appetite suppression with glucagon-driven energy expenditure.
Receptors
GLP-1 receptorGlucagon receptor
Half-life: Consistent with once-weekly dosing in published trial protocols.
Ask Regenexa AI about Mazdutide
Get plain-language answers on mechanism, evidence and how it compares to other peptides — grounded in Regenexa's verified data.
Ask Regenexa AI →Available following assessmentTake Assessment
GLP-3 R
Cagrilintide
CagriSema
Survodutide